Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — 1H 2018 Earnings Presentation

13 slides from Novonesis A/s Class B's earnings presentation, Aug 10, 2018

  1. Slide 1: Novozymes Conference Call 1H 2018

    Novozymes Conference Call 1H 2018 August 10, 2018

  2. Slide 2: Highlights

    Highlights Distribution of sales and organic growth, 1H y/y Satisfactory first half with 4% organic sales growth -6% • Organic sales growth +4% (Q2: +5%) 6% +3% • Household Care -1% (Q2: -2%) 14% -1% 32% • Food & Beverages +4% (Q2: +4%) • Bioenergy +14% (Q2: +20%) 19% • Agriculture & Feed +3% (Q2: +

  3. Slide 3: Organic sales growth by geography

    Organic sales growth by geography -1% 1H y/y +6% 1H y/y 37% of sales +7% 33% 1H y/y of sales 21% of sales +7% 1H y/y 9% +7% 35% Emerging markets of sales 1H y/y 65% Developed markets +2% 1H y/y 3

  4. Slide 4: Household Care

    Household Care 32% of sales Sales softer than expected in Q2 1H y/y organic sales growth • Organic growth 1H 2018 y/y -1%; Q2 2018 y/y -2% 5% 4% • Mixed performance in laundry; soft developed markets, good development in emerging markets from local customers • Q2 impacted by customers’ region-specif

  5. Slide 5: Food & Beverages

    Food & Beverages 29% of sales Broad-based performance in the first half 1H y/y organic sales growth • Organic growth 1H 2018 y/y +4%; Q2 2018 y/y +4% 8% • Nutrition performed well, supported by our Saphera® product for lactose reduction in dairy 5% 5% 4% • Starch delivered growth across markets, alt

  6. Slide 6: Bioenergy

    Bioenergy 19% of sales Strong growth momentum in conventional biofuels 1H y/y organic sales growth • Organic growth 1H 2018 y/y +14%; Q2 2018 y/y +20% • US and global ethanol production estimated to be up 2-3% in Q2 y/y vs. 26% flat in Q1 y/y. Inventories remain elevated and producer margins tight 1

  7. Slide 7: Agriculture & Feed

    Agriculture & Feed 14% of sales Sales picking up in BioAg; Feed remains subdued due to 1H y/y organic sales growth challenging markets 19% • Organic growth 1H 2018 y/y +3%; Q2 2018 y/y +13% • BioAg sales strong in Q2; Acceleron® B-300/B-360 benefited Q2 sales due to preparation for the 2019 planting

  8. Slide 8: R&D update

    R&D update Animal Health & Nutrition BioAg New enzyme launch with DSM Acceleron® B-360 ST for corn • Novel enzyme improving digestion and • Promotes symbiosis between microbes and gut health in chickens corn plants to strengthen root systems and increase plants’ access to nutrients • Estimated in-ma

  9. Slide 9: 1H 2018 financials

    1H 2018 financials Satisfactory growth; solid earnings • Overall 1H organic sales growth roughly as expected at 4% Key financials Realized Realized (DKKm) 1H’18 1H’17 • 7% organic sales growth in emerging markets. Developed markets 2% driven by Household Care as a negative Organic sales 4% 3% growth

  10. Slide 10: 2018 outlook

    2018 outlook 2018 outlook maintained across parameters • Organic sales growth expectation of 4-6% with growth expected from Key financials Realized Outlook (DKKm) 1H’18 2018 all major segments • Negative impact from currencies on reported sales reduced to ~3% Organic sales 4% 4-6% growth from previo

  11. Slide 11: Summary

    Summary • On track to deliver 4-6% organic sales growth for 2018 • Focus on strategic priorities for 2018 and beyond • Significant and exciting innovation in Agriculture & Feed • First commercial product from freshness & hygiene technology on the shelves in the Philippines • Agenda for Capital Marke

  12. Slide 12: Our business is about turning amazing science into sustainable biological answers

    Our business is about turning amazing science into sustainable biological answers in a growing world 6,500 2nd 48% 76 million More than 6,500 active and In 2017, Science Magazine Market leader in industrial In 2017, our customers pending patents ranked Novozymes the enzymes with an estimated avoided

  13. Slide 13: Forward-looking statements

    Forward-looking statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "bel

Novozymes — 1H 2018 Earnings Presentation on 6ix